Showing results (981-990 of 1,163) with videos related to

Sort By:
Pageof 117
JACC. Heart Failure|September 28, 2023
Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF: The DELIVER TrialAlexander Peikert, Bradley A Bart, Muthiah Vaduganathan, et al.
Global Heart|September 14, 2020
Correction: Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource SettingsDorairaj Prabhakaran, Pablo Perel, Ambuj Roy, et al.
European Heart Journal|March 4, 2020
The association of long-term outcome and biological sex in patients with acute heart failure from different geographic regionsJustina Motiejūnaitė, Eiichi Akiyama, Alain Cohen-Solal, et al.
European Journal of Heart Failure|September 2, 2022
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trialJohn W Ostrominski, Muthiah Vaduganathan, Brian L Claggett, et al.
The American Journal of Cardiology|April 14, 2019
Sex Differences in 1-Year Rehospitalization for Heart Failure and Myocardial Infarction After Primary Percutaneous Coronary InterventionHuili Zheng, Ling Li Foo, Huay Cheem Tan, et al.
JACC. Heart Failure|July 1, 2017
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF TrialScott D Solomon, Adel R Rizkala, Jianjian Gong, et al.
European Journal of Heart Failure|August 17, 2018
Heart failure with preserved ejection fraction in AsiaJasper Tromp, Tiew-Hwa Teng, Wan Ting Tay, et al.
JAMA Cardiology|February 22, 2023
Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid-Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout: A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVERJawad H Butt, Kieran F Docherty, Brian L Claggett, et al.
European Journal of Heart Failure|June 26, 2020
Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registriesWouter Ouwerkerk, Tiew-Hwa K Teng, Jasper Tromp, et al.
JACC. Asia|February 19, 2024
Effects of Dapagliflozin in Patients in Asia: A Post Hoc Subgroup Analysis From the DELIVER TrialXiaowen Wang, Carolyn S P Lam, Muthiah Vaduganathan, et al.
Pageof 117